What is the current Codeine Phosphate market size?

The Codeine Phosphate market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Codeine Phosphate market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driving future outlook.

What are the key drivers of the Codeine Phosphate market?

Increasing demand for pain management and rising prevalence of diseases drive the market growth.

What are the major challenges facing the Codeine Phosphate market?

Stringent regulations and side effects associated with codeine phosphate pose significant challenges.

Which regions are the leaders in the Codeine Phosphate market?

North America and Europe are the leading regions, accounting for the largest market share.

Who are the top companies in the Codeine Phosphate market?

Pfizer, Johnson & Johnson, and Sanofi are among the top companies in the Codeine Phosphate market.

What are the future opportunities in the Codeine Phosphate market?

Emerging markets and increasing use in combination therapies offer future opportunities for growth.

How does technology impact the Codeine Phosphate market?

Advancements in technology improve manufacturing processes and enhance product quality and safety.

What is the current regulatory landscape of the Codeine Phosphate market?

The market is regulated by stringent laws and guidelines, ensuring safe and controlled use.

Which Companies Lead the Codeine Phosphate Market in 2026?

Codeine Phosphate by Application (Narcotic Analgesic, Antitussive, Others), by Types (Extracted from Opium, Synthesized by Morphine), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 173

Forecast Period: 2026 - 2033

Market Size: $214.1 million

CAGR: 4.1%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 173

Forecast Period: 2026 - 2033

Market Size: $214.1 million

CAGR: 4.1%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Codeine Phosphate Market Size | CAGR 4.1% Forecast 2033

Which Companies Lead the Codeine Phosphate Market in 2026?

🏭 Chemicals & Materials🌍 Global

Pages: 173

Forecast Period: 2026 - 2033

Market Size: $214.1 million

CAGR: 4.1%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 173

Forecast Period: 2026 - 2033

Market Size: $214.1 million

CAGR: 4.1%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Codeine Phosphate Market Overview

The Codeine Phosphate market refers to the global industry involved in the production and distribution of codeine phosphate, a medication used to treat pain and cough. As a significant segment of the pharmaceutical industry, the Codeine Phosphate market size is substantial, with an estimated value of approximately $1.3 billion in 2025. The growth outlook for the Codeine Phosphate market is promising, with a market forecast indicating a compound annual growth rate (CAGR) of around 4-5% during the forecast period of 2026-2033, driven by factors such as increasing demand for pain management and expanding industry expansion. The scope of this market encompasses various synonyms, including codeine phosphate API, codeine phosphate tablets, and codeine phosphate solutions.

Loading chart…

Key forces shaping the Codeine Phosphate industry include technology shifts towards more efficient manufacturing processes, regulations regarding the use of controlled substances, and changing consumer behavior towards more effective and safer pain management options. The largest region for the Codeine Phosphate market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing demand for pharmaceuticals and expanding healthcare infrastructure. Macro drivers, such as an aging population and rising healthcare expenditure, are also expected to contribute to the growth of the Codeine Phosphate market during the forecast period.

Report Overview

Report Attribute	Details
Market size value in 2025	214.10 million
Revenue forecast in 2033	373.40 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Macfarlan Smith; Francopia; Noramco; Weifa; Mallinckrodt; Temad; GSK; Alkaloida; Tas. Alkaloids; Alcaliber; Fine Chemicals; Aesica; Sino Pharm; Sri Krishna; TPI
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Codeine Phosphate market is experiencing significant fluctuations due to various factors. Understanding these dynamics is crucial for stakeholders to navigate the market effectively and capitalize on emerging opportunities.

Growth Drivers2 items

Increasing demand for effective pain management solutions is driving the growth of the Codeine Phosphate market size, with pharmaceutical companies investing heavily in research and development to create innovative products.

Government initiatives to improve healthcare infrastructure and accessibility are also contributing to the growth forecast of the Codeine Phosphate market, particularly in emerging economies.

Restraints2 items

Stringent regulations and strict guidelines governing the production and distribution of Codeine Phosphate are limiting the market's potential, as companies must adhere to good manufacturing practices and comply with regulatory requirements.

The high risk of addiction and abuse associated with Codeine Phosphate is also hindering market growth, as governments and healthcare organizations implement measures to curb misuse and promote responsible prescribing practices.

Opportunities2 items

The growing awareness of pain management and the increasing prevalence of chronic pain conditions are creating opportunities for pharmaceutical companies to develop targeted treatments and capitalize on the Codeine Phosphate market size.

The emergence of new technologies and formulations, such as extended-release and abuse-deterrent products, is also expected to drive growth in the Codeine Phosphate market, as companies invest in research and development to stay competitive.

Challenges2 items

The Codeine Phosphate market is highly competitive, with numerous players operating in the space, which can make it challenging for companies to differentiate themselves and maintain market share.

Additionally, the complex and ever-evolving regulatory landscape poses a significant challenge for stakeholders, as they must navigate changing guidelines and requirements to ensure compliance and avoid penalties or litigation.

Market Segmentation

Loading chart…

The Application segment of the Codeine Phosphate market refers to the various uses of the medication, including cough suppression and pain relief. This segment contributes significantly to the overall Codeine Phosphate market size, as it accounts for the majority of the medication's usage. Understanding the Codeine Phosphate segmentation by application is crucial for market players to identify opportunities and trends in the industry.

The Types segment of the Codeine Phosphate market includes subtypes such as Immediate Release and Sustained Release. Each subtype has its own unique characteristics and advantages, and contributes to the overall market size. The Codeine Phosphate market taxonomy reveals that the types segment is a critical component of the market, as it directly affects the efficacy and safety of the medication. Analyzing the market taxonomy and Codeine Phosphate segmentation by types can provide valuable insights for market players to develop effective strategies.

Codeine Phosphate Segmentation Breakdown7 items

Application

Narcotic Analgesic

Antitussive

Others

Types

Extracted from Opium

Synthesized by Morphine

Regional Insights

Loading chart…

The Codeine Phosphate market growth is anticipated to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market share. This region's dominance can be attributed to key drivers such as increased adoption of Codeine Phosphate in the pharmaceutical industry, government policies supporting the development of new medications, and investments in healthcare infrastructure. The fastest-growing region is expected to be Latin America, driven by demographic changes, expanding ecosystem maturity, and rising investments in the healthcare sector.

In North America, key drivers include established infrastructure, mature ecosystem, and high demand for Codeine Phosphate. Europe's growth is influenced by stringent regulations, increased research, and growing awareness about the benefits of Codeine Phosphate. The Middle East & Africa region is expected to witness growth due to growing investments, improving demographics, and expanding healthcare services.

The regional forecast indicates a significant Codeine Phosphate market growth in Asia Pacific, driven by rising demand and increased adoption. Latin America's growth is expected to be driven by demographic changes and expanding ecosystem maturity. Understanding these regional trends is crucial for stakeholders to develop effective strategies and capitalize on emerging opportunities in the Codeine Phosphate market.

Competitive Landscape

The Codeine Phosphate market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. The Codeine Phosphate competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory approvals, while local companies emphasize distribution and pricing strategies.

Companies in the Codeine Phosphate market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies focus on technology, service model, channel strength, customization, and cost advantages. The following companies have adopted distinct strategies:

Macfarlan Smith: regional expansion

Francopia: premium pricing

Noramco: vertical integration

Weifa: OEM tie-ups

Mallinckrodt: innovation pipeline

Temad: local manufacturing

Key Codeine Phosphate Companies15 items

Macfarlan Smith

Francopia

Noramco

Weifa

Mallinckrodt

Temad

GSK

Alkaloida

Tas. Alkaloids

Alcaliber

Fine Chemicals

Aesica

Sino Pharm

Sri Krishna

TPI

Market Ecosystem

The Codeine Phosphate ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. This complex network creates and captures value through the development, manufacturing, and distribution of Codeine Phosphate products. Understanding the Codeine Phosphate ecosystem is crucial for conducting a thorough value chain analysis.

Raw material suppliers — provide pharmaceutical-grade codeine

OEMs / manufacturers — produce Codeine Phosphate products

Distributors / channel partners — deliver products to healthcare providers

Service providers / after-sales — offer support and maintenance services

End users / buyers — healthcare providers and patients

Regulators/standards bodies — establish and enforce quality standards

Data/analytics providers — track sales, usage, and patient outcomes

In the Codeine Phosphate ecosystem, control points are primarily held by regulators and manufacturers, who influence adoption through standards and product development. Dependency risks arise from input constraints, such as raw material availability, and regulatory approvals. Switching costs and partnerships between manufacturers and distributors can also impact the ecosystem. Furthermore, regional differences in regulations and healthcare systems can lead to variations in the Codeine Phosphate ecosystem across different regions.

Recent Industry Insights

The Codeine Phosphate industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between pharmaceutical companies have led to the creation of new products and technologies, enhancing the overall market landscape. Notable mergers and acquisitions have also occurred, resulting in market consolidation and increased competition. Furthermore, regulatory changes have imposed stricter guidelines on the production and distribution of Codeine Phosphate, affecting the industry's dynamics.

In addition to these developments, there has been a noticeable shift in consumer trends, with a growing preference for alternative pain management solutions. This has prompted companies to invest in research and development, exploring new product launches and technologies. Funding rounds and expansions have also been observed, as companies strive to stay ahead in the market and capitalize on emerging Codeine Phosphate industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Codeine Phosphate market. The Codeine Phosphate market outlook indicates moderate attractiveness due to its widespread application in pain management. The competitive intensity is relatively high, with multiple players operating in the market. In the long term, the market is expected to witness steady growth driven by increasing demand for effective pain management solutions.

The innovation landscape is characterized by ongoing research and development efforts focused on improving the efficacy and safety of Codeine Phosphate formulations. However, the demand–supply balance may be affected by regulatory changes and fluctuations in raw material availability. Key risk factors include stringent regulations and fluctuating demand, which may impact market growth. Overall, the Codeine Phosphate market is poised for stable growth, driven by its established use in the pharmaceutical industry.

11 items

1. Executive Summary

2. Codeine Phosphate Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Codeine Phosphate Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Codeine Phosphate Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Narcotic Analgesic

6.1.2. Antitussive

6.1.3. Others

6.2. Global Codeine Phosphate Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Extracted from Opium

6.2.2. Synthesized by Morphine

6.3. Global Codeine Phosphate Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Codeine Phosphate Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Codeine Phosphate Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Codeine Phosphate Market Competition by Key Manufacturers

8.1. Global Codeine Phosphate Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Codeine Phosphate: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Macfarlan Smith

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Francopia

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Noramco

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Weifa

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Mallinckrodt

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Temad

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. GSK

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Alkaloida

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Tas. Alkaloids

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Alcaliber

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Fine Chemicals

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Aesica

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Sino Pharm

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Sri Krishna

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. TPI

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Codeine Phosphate Market

Figure 4: Global Codeine Phosphate Market: Drivers

Figure 5: Global Codeine Phosphate Market: Challenges

Figure 6: Global Codeine Phosphate Market: Trends

Figure 7: Global Codeine Phosphate Market: Opportunity

Figure 8: Global Codeine Phosphate Market: Restraint

Figure 9: Global Codeine Phosphate Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Codeine Phosphate Market Value (USD Million) By Region

Figure 15: Global Codeine Phosphate Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Codeine Phosphate Market Value (USD Million) By Region

Figure 23: Global Codeine Phosphate Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Codeine Phosphate Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Codeine Phosphate Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Codeine Phosphate Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Codeine Phosphate Market Value (USD Million) By Region

Table 10: Global Codeine Phosphate Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Codeine Phosphate Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Codeine Phosphate Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Codeine Phosphate Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Macfarlan Smith Basic Information And Sales Area

Table 31: Macfarlan Smith. Products Portfolio

Table 32: Francopia Basic Information And Sales Area

Table 33: Francopia. Products Portfolio

Table 34: Noramco Basic Information And Sales Area

Table 35: Noramco. Products Portfolio

Table 36: Weifa Basic Information And Sales Area

Table 37: Weifa. Products Portfolio

Table 38: Mallinckrodt Basic Information And Sales Area

Table 39: Mallinckrodt. Products Portfolio

Table 40: Temad Basic Information And Sales Area

Table 41: Temad. Products Portfolio

Table 42: GSK Basic Information And Sales Area

Table 43: GSK. Products Portfolio

Table 44: Alkaloida Basic Information And Sales Area

Table 45: Alkaloida. Products Portfolio

Table 46: Tas. Alkaloids Basic Information And Sales Area

Table 47: Tas. Alkaloids. Products Portfolio

Table 48: Alcaliber Basic Information And Sales Area

Table 49: Alcaliber. Products Portfolio

Table 50: Fine Chemicals Basic Information And Sales Area

Table 51: Fine Chemicals. Products Portfolio

Table 52: Aesica Basic Information And Sales Area

Table 53: Aesica. Products Portfolio

Table 54: Sino Pharm Basic Information And Sales Area

Table 55: Sino Pharm. Products Portfolio

Table 56: Sri Krishna Basic Information And Sales Area

Table 57: Sri Krishna. Products Portfolio

Table 58: TPI Basic Information And Sales Area

Table 59: TPI. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Codeine Phosphate Market Value (USD Million) By Region

Table 65: Global Codeine Phosphate Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Codeine Phosphate Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	214.10 million
Revenue forecast in 2033	373.40 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Macfarlan Smith; Francopia; Noramco; Weifa; Mallinckrodt; Temad; GSK; Alkaloida; Tas. Alkaloids; Alcaliber; Fine Chemicals; Aesica; Sino Pharm; Sri Krishna; TPI
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options